This inventor holds 3 USPTO granted patents. Top assignees: Intron Biotechnology, Inc., Seoul National University. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Innovations of Dong Chan Oh
Introduction
Dong Chan Oh is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of peptide compounds with potential therapeutic applications. With a total of 3 patents, his work focuses on innovative solutions for cancer treatment and infectious diseases.
Latest Patents
Dong Chan Oh's latest patents include a novel peptide compound, a production method therefor, and its use in cancer prevention and treatment. This peptide compound exhibits anticancer activity, making it a promising candidate for therapeutic applications. Additionally, he has developed a pharmaceutical composition aimed at preventing or treating infections caused by mycobacterium species. This composition includes a peptide compound and is designed to alleviate inflammatory responses associated with such infections.
Career Highlights
Throughout his career, Dong Chan Oh has worked with notable organizations, including Intron Biotechnology, Inc. and Seoul National University. His experience in these institutions has allowed him to advance his research and contribute to significant scientific advancements.
Collaborations
Some of his notable coworkers include Sang Kook Lee and Jong Heon Shin. Their collaborative efforts have further enhanced the impact of his research in the field of biotechnology.
Conclusion
Dong Chan Oh's innovative work in peptide compounds and pharmaceutical compositions highlights his commitment to advancing medical science. His contributions have the potential to significantly impact cancer treatment and infectious disease management.